Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Medical - Devices Industry — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.3:1
Daily Buy & Sell Volume

RxSight, Inc. (RXST)

Kurtz Ronald M MD — Chief Medical Officer
Sep 2, 2026
Sale
Shares
5,100
Price
$6.96
Total Value
$35.50K
Shares Held After
71,775
% of Holdings
6.6%

RxSight, Inc. (RXST)

Goldshleger Ilya — Chief Operating Officer
Sep 2, 2026
Sale
Shares
2,041
Price
$6.96
Total Value
$14.21K
Shares Held After
81,509
% of Holdings
2.4%

RxSight, Inc. (RXST)

Wilterding Mark — Chief Financial Officer
Sep 2, 2026
Sale
Shares
7,765
Price
$6.96
Total Value
$54.04K
Shares Held After
25,049
% of Holdings
23.7%
Shares
35,769
Price
$3.12
Total Value
$111.57K
Shares Held After
11,563,425
% of Holdings
0.3%

SI-BONE, Inc. (SIBN)

DUNN JEFFREY W — Director
Sep 1, 2026
Sale
Shares
1,367
Price
$18.91
Total Value
$25.85K
Shares Held After
16,057
% of Holdings
7.8%

SI-BONE, Inc. (SIBN)

DUNN JEFFREY W — Director
Sep 1, 2026
Sale
Shares
18,633
Price
$18.91
Total Value
$352.31K
Shares Held After
17,424
% of Holdings
51.7%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — Chief Commercial Officer
Sep 1, 2026
Sale
Shares
1,746
Price
$2.26
Total Value
$3.95K
Shares Held After
449,832
% of Holdings
0.4%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — Chief Commercial Officer
Sep 1, 2026
Sale
Shares
1,530
Price
$2.26
Total Value
$3.46K
Shares Held After
451,578
% of Holdings
0.3%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — Chief Commercial Officer
Sep 1, 2026
Sale
Shares
2,390
Price
$2.26
Total Value
$5.40K
Shares Held After
453,108
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Rose Geoffrey Beran — Chief Commercial Officer
Sep 1, 2026
Sale
Shares
2,213
Price
$2.26
Total Value
$5.00K
Shares Held After
455,498
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth — Chief Science&Techn. Officer
Sep 1, 2026
Sale
Shares
5,863
Price
$2.26
Total Value
$13.25K
Shares Held After
316,994
% of Holdings
1.8%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth — Chief Science&Techn. Officer
Sep 1, 2026
Sale
Shares
3,618
Price
$2.26
Total Value
$8.18K
Shares Held After
322,857
% of Holdings
1.1%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth — Chief Science&Techn. Officer
Sep 1, 2026
Sale
Shares
2,121
Price
$2.26
Total Value
$4.79K
Shares Held After
326,475
% of Holdings
0.6%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth — Chief Science&Techn. Officer
Sep 1, 2026
Sale
Shares
2,643
Price
$2.26
Total Value
$5.97K
Shares Held After
328,596
% of Holdings
0.8%
Sep 1, 2026
Sale
Shares
37,784
Price
$2.26
Total Value
$85.39K
Shares Held After
1,137,936
% of Holdings
3.2%
Sep 1, 2026
Sale
Shares
4,098
Price
$2.26
Total Value
$9.26K
Shares Held After
1,175,720
% of Holdings
0.3%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
4,827
Price
$2.26
Total Value
$10.91K
Shares Held After
361,827
% of Holdings
1.3%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
3,476
Price
$2.26
Total Value
$7.86K
Shares Held After
366,654
% of Holdings
0.9%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
2,224
Price
$2.26
Total Value
$5.03K
Shares Held After
370,130
% of Holdings
0.6%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
3,807
Price
$2.26
Total Value
$8.60K
Shares Held After
372,354
% of Holdings
1.0%

Orthofix Medical Inc. (OFIX)

Fisher Patrick — President, Global Limb Recon
Sep 1, 2026
Sale
Shares
150
Price
$9.39
Total Value
$1.41K
Shares Held After
51,069
% of Holdings
0.3%
Sep 1, 2026
Sale
Shares
35,769
Price
$3.12
Total Value
$111.57K
Shares Held After
11,563,425
% of Holdings
0.3%
Sep 1, 2026
Purchase
Shares
1,790
Price
$4.57
Total Value
$8.18K
Shares Held After
2,244
% of Holdings
79.8%
Sep 1, 2026
Sale
Shares
10,131
Price
$23.10
Total Value
$234.03K
Shares Held After
6,526,633
% of Holdings
0.2%
Sep 1, 2026
Sale
Shares
10,131
Price
$23.10
Total Value
$234.03K
Shares Held After
6,526,633
% of Holdings
0.2%
Sep 1, 2026
Sale
Shares
10,131
Price
$23.10
Total Value
$234.03K
Shares Held After
6,526,633
% of Holdings
0.2%
Shares
78,145
Price
$3.14
Total Value
$245.61K
Shares Held After
11,599,194
% of Holdings
0.7%
Aug 31, 2026
Sale
Shares
78,145
Price
$3.14
Total Value
$245.61K
Shares Held After
11,599,194
% of Holdings
0.7%

LivaNova PLC (LIVN)

Bianchi Francesco — Director
Aug 31, 2026
Sale
Shares
1,650
Price
$79.72
Total Value
$131.54K
Shares Held After
7,934
% of Holdings
17.2%
Aug 31, 2026
Sale
Shares
1,276
Price
$4.66
Total Value
$5.95K
Shares Held After
454
% of Holdings
73.8%

Edwards Lifesciences Corp (EW)

Dahl Andrew M. — SVP, Corporate Controller
Aug 31, 2026
Sale
Shares
544
Price
$91.06
Total Value
$49.53K
Shares Held After
14,868
% of Holdings
3.5%
Aug 31, 2026
Purchase
Shares
27,304
Price
$3.54
Total Value
$96.60K
Shares Held After
294,784
% of Holdings
9.3%
Aug 28, 2026
Sale
Shares
326,700
Price
$23.04
Total Value
$7.53M
Shares Held After
6,536,764
% of Holdings
4.8%
Aug 28, 2026
Sale
Shares
326,700
Price
$23.04
Total Value
$7.53M
Shares Held After
6,536,764
% of Holdings
4.8%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Aug 28, 2026
Sale
Shares
10
Price
$182.50
Total Value
$1.82K
Shares Held After
73,890
% of Holdings
0.0%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Aug 28, 2026
Sale
Shares
6,091
Price
$181.19
Total Value
$1.10M
Shares Held After
73,900
% of Holdings
7.6%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Aug 28, 2026
Sale
Shares
7,643
Price
$180.25
Total Value
$1.38M
Shares Held After
79,991
% of Holdings
8.7%
Aug 28, 2026
Sale
Shares
2,091
Price
$7.90
Total Value
$16.52K
Shares Held After
1,730
% of Holdings
54.7%
Aug 28, 2026
Sale
Shares
4,932
Price
$7.07
Total Value
$34.87K
Shares Held After
1,730
% of Holdings
74.0%
Aug 28, 2026
Purchase
Shares
5,981
Price
$6.35
Total Value
$37.98K
Shares Held After
1,730
% of Holdings
345.7%
Aug 28, 2026
Sale
Shares
326,700
Price
$23.04
Total Value
$7.53M
Shares Held After
6,536,764
% of Holdings
4.8%
Aug 28, 2026
Purchase
Shares
12,376
Price
$5.21
Total Value
$64.48K
Shares Held After
1,730
% of Holdings
715.4%
Aug 28, 2026
Sale
Shares
7,800
Price
$8.83
Total Value
$68.87K
Shares Held After
4,803,541
% of Holdings
0.2%
Aug 28, 2026
Purchase
Shares
37,537
Price
$3.44
Total Value
$129.01K
Shares Held After
267,480
% of Holdings
14.0%
Aug 28, 2026
Sale
Shares
2,644
Price
$89.98
Total Value
$237.91K
Shares Held After
17,984
% of Holdings
12.8%

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Wambeke David J. — Chief Business Officer
Aug 27, 2026
Purchase
Shares
33,333
Price
$2.01
Total Value
$67.00K
Shares Held After
199,999
% of Holdings
16.7%

DEXCOM INC (DXCM)

Stern Sadie — EVP Chief People&Culture Off
Aug 27, 2026
Sale
Shares
2,565
Price
$88.37
Total Value
$226.67K
Shares Held After
126,043
% of Holdings
2.0%
Aug 27, 2026
Purchase
Shares
10,925
Price
$3.18
Total Value
$34.75K
Shares Held After
229,943
% of Holdings
4.8%
Aug 26, 2026
Purchase
Shares
9,708
Price
$3.29
Total Value
$31.93K
Shares Held After
219,018
% of Holdings
4.4%

BIOMERICA INC (BMRA)

Irani Zackary S. — Director
Aug 26, 2026
Purchase
Shares
31,250
Price
$1.60
Total Value
$50.00K
Shares Held After
242,570
% of Holdings
12.9%
Version: v26.7.3